Cypher class action suit?
This article was originally published in The Gray Sheet
Executive Summary
Kenneth B. Moll & Associates will decide by year-end whether to pursue a class action suit against Johnson & Johnson/Cordis for deaths related to implantation of its sirolimus-eluting stent. Moll currently is conducting an investigation of Cypher patient data FDA released in October that estimated a 0.01% worldwide mortality rate for the device (1"The Gray Sheet" Nov. 3, 2003, p. 4). In June, the Chicago law firm brought a class action suit against Guidant because of deaths related to its Ancure AAA system; the suit is currently in discovery...